Drug profile · INN
terbinafine hydrochloride
TERBINAFINE HYDROCHLORIDE
terbinafine hydrochloride (TERBINAFINE HYDROCHLORIDE) is a squalene monooxygenase inhibitor. Route of administration: topical. Current US regulatory status: approved.
Drug details — terbinafine hydrochloride
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
terbinafine hydrochloride (TERBINAFINE HYDROCHLORIDE) is a squalene monooxygenase inhibitor. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Squalene monooxygenase inhibitor
Primary target: Squalene monooxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is terbinafine hydrochloride?
terbinafine hydrochloride (TERBINAFINE HYDROCHLORIDE) is a squalene monooxygenase inhibitor. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for terbinafine hydrochloride?
TERBINAFINE HYDROCHLORIDE is a marketed brand name for terbinafine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of terbinafine hydrochloride?
terbinafine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.